Heritage Wealth Advisors’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-17
Closed -$53 – 298
2026
Q2
$53 Hold
17
– – ﹤0.01% 679
2026
Q1
$32 Sell
17
-1
-6% -$3 ﹤0.01% 670
2025
Q4
$89 Hold
18
– – ﹤0.01% 579
2025
Q3
$181 Hold
18
– – ﹤0.01% 568
2025
Q2
$147 Hold
18
– – ﹤0.01% 557
2025
Q1
$163 Hold
18
– – ﹤0.01% 560
2024
Q4
$394 Hold
18
– – ﹤0.01% 603
2024
Q3
$656 Hold
18
– – ﹤0.01% 582
2024
Q2
$656 Hold
18
– – ﹤0.01% 492
2024
Q1
$588 Hold
18
– – ﹤0.01% 513
2023
Q4
$698 Hold
18
– – ﹤0.01% 521
2023
Q3
$557 Hold
18
– – ﹤0.01% 484
2023
Q2
$583 Hold
18
– – ﹤0.01% 524
2023
Q1
$777 Hold
18
– – ﹤0.01% 536
2022
Q4
$1.32K Hold
18
– – ﹤0.01% 515
2022
Q3
$1.68K Hold
18
– – ﹤0.01% 486
2022
Q2
$3K Hold
18
– – ﹤0.01% 509
2022
Q1
$3K Hold
18
– – ﹤0.01% 487
2021
Q4
$5K Hold
18
– – ﹤0.01% 480
2021
Q3
$5.11K Hold
18
– – ﹤0.01% 473
2021
Q2
$4.33K Hold
18
– – ﹤0.01% 492
2021
Q1
$5.01K Hold
18
– – ﹤0.01% 496
2020
Q4
$5K Hold
18
– – ﹤0.01% 486
2020
Q3
$7.14K Hold
18
– – ﹤0.01% 410
2020
Q2
$10.2K Hold
18
– – ﹤0.01% 381
2020
Q1
$4K Buy
+18
New +$3.12K ﹤0.01% 404

Other funds holding CODX

Heritage Wealth Advisors's CODX Position: Q3 2026 in Review

Heritage Wealth Advisors sold out of Co-Diagnostics (CODX) in Q3 2026, closing a stake of 17 shares — an estimated $53 sold.

Heritage Wealth Advisors first reported a position in CODX in Q1 2020 and held it in 26 quarters. The position peaked at $10.2K in Q2 2020. 24 funds tracked by Wall St. Rank hold CODX as of Q3 2026.

  • Heritage Wealth Advisors reported no remaining Co-Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Heritage Wealth Advisors sold 17 Co-Diagnostics shares in Q3 2026, an estimated $53.
  • Heritage Wealth Advisors first reported a position in Co-Diagnostics in Q1 2020 and held it in 26 quarters.
  • Heritage Wealth Advisors's Co-Diagnostics position peaked at $10.2K in Q2 2020.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2026.

Based on Heritage Wealth Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.